| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 70,143 | 62,814 | 58,316 | 94,870 | | Cost of Revenue | 29,159 | 27,349 | 26,726 | 43,563 | | | Gross Profit | 40,984 | 35,465 | 31,590 | 51,307 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,607 | 7,513 | 9,044 | 11,635 | | Non Recurring |
-
|
-
|
-
| 641,000 | | Others | 25,627 | 21,996 | 24,040 | 41,574 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,974 | 5,956 | (1,494) | (642,902) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (12,368) | (59,018) | 47,612 | 239,365 | | Earnings Before Interest And Taxes | (36,900) | (53,062) | 46,118 | (403,537) | | Interest Expense | (22,428) | 10,515 | 11,913 | 13,707 | | Income Before Tax | (14,472) | (63,577) | 34,205 | (417,244) | | Income Tax Expense | (9,200) | (4,100) | 9,000 | (3,200) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,854) | (59,477) | 25,205 | (414,044) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,272) | (59,477) | 25,205 | (414,044) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,272) | ($59,477) | $25,205 | ($414,044) |
|
1.48% Nasdaq 
Income Statement
